MiMedx Group Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for MiMedx Group, Inc. (MDXG) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income42.0058.23-19.95-10.29-49.28
Depreciation & Amortization6.043.435.775.186.86
Deferred Income Tax12.47-37.800.000.000.00
Stock Based Compensation16.9316.9611.3314.1615.36
Change in Working Capital-5.43-18.42-6.16-19.35-15.69
Change in Accounts Receivable-2.55-12.24-5.94-10.62-3.10
Change in Inventory-2.36-7.84-1.79-1.41-1.26
Change in Accounts Payable-1.410.780.84-0.160.18
Change in Other Working Capital0.891.881.80-7.17-1.49
Other Operating Activities-5.811.8814.24-0.959.19
Net Cash from Operating Activities66.2026.78-17.89-1.98-30.26
Investing Activities
Capital Expenditures-1.68-1.992.51-3.22-4.23
Acquisitions-7.860.000.000.000.00
Sales/Maturities of Investments0.000.00-0.17-0.25-0.33
Other Investing Activities0.00-0.17-0.170.080.00
Net Cash from Investing Activities-9.58-2.16-2.66-3.40-4.56
Financing Activities
Debt Repayment-31.720.00-0.04-0.04-83.87
Common Stock Issued0.001.000.651.440.41
Common Stock Repurchased-2.64-9.52-1.19-4.75-2.33
Other Financing Activities0.16-0.05-1.19-4.75-12.14
Net Cash from Financing Activities-34.20-8.57-0.58-3.3561.56
Summary
Net Change in Cash22.4216.05-21.13-8.7326.74
Cash at Beginning of Period82.0065.9587.0895.8169.07
Cash at End of Period104.4282.0065.9587.0895.83
Free Cash Flow64.5224.79-20.38-5.20-34.49
Supplemental Disclosures
Interest Paid2.706.034.574.337.46
Income Taxes Paid3.25-0.550.180.170.21